Premium
Can thrombotic events be a major concern in hepatocellular carcinoma patients under systemic treatment during SARS‐Cov‐2?
Author(s) -
Fonseca Leonardo,
Carrilho Flair José
Publication year - 2020
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.14545
Subject(s) - hepatocellular carcinoma , covid-19 , medicine , systemic risk , betacoronavirus , gastroenterology , virology , intensive care medicine , disease , financial crisis , outbreak , infectious disease (medical specialty) , economics , macroeconomics